According to Aurobindo Pharma 's latest financial reports and stock price the company's current Operating Margin is 11.18%. At the end of 2023 the company had an Operating Margin of 10.61%.
Year | Operating Margin | Change |
---|---|---|
2023 | 10.61% | -26.48% |
2022 | 14.43% | -51.73% |
2021 | 29.90% | 81.65% |
2020 | 16.46% | 2.38% |
2019 | 16.08% | -19.64% |
2018 | 20.01% | -4.14% |
2017 | 20.87% | 4.65% |
2016 | 19.95% | 10.8% |
2015 | 18.00% | -5.58% |
2014 | 19.06% | 194.69% |
2013 | 6.47% | -238.34% |
2012 | -4.68% | -125.66% |
2011 | 18.22% | -13.38% |
2010 | 21.04% | 791.55% |
2009 | 2.36% | -80.3% |
2008 | 11.98% | 23.17% |
2007 | 9.72% | 57.22% |
2006 | 6.18% | 346.89% |
2005 | 1.38% | -86.35% |
2004 | 10.14% |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.